Skip To Main Content
Nancy Pham on Muck Rack

Nancy Pham

As seen in: MSN, Wiley Online Library, CNBC, U.S. News and World Report, JAMA Network, MDEdge, The Connecticut Mirror, AJNR Podcasts, HBW Insight, Citeline and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Nancy

Contact Nancy, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Consensus Guidelines for Staging and Surveillance Imaging in Cutaneous Squamous Cell Carcinoma

|
By Bina Kassamali, Jonathan D Schoenfeld, Rosh K. Sethi, Richard Bakst, Christopher Barker, Alok Bhatt, Carol R. Bradford, Paul Bunch, David Carr, John Carucci Verified, Sunandana Chandra, Michelle Chen Verified, Karen Connolly, Addison M. Demer, Bently P. Doonan, Kevin S. Emerick, Ben Friedman, Thomas J. Galloway, Jessica Geiger, Jeffrey P. Guenette, Hillary Kelly, Nikhil I. Khushalani, Laurie L. Kohen, Shlomo Koyfman, Kim O Learned, Justin J. Leitenberger, Elizabeth J. Lilley, John Lukens, Theresa Medina, Devarati Mitra, David M. Ozog, Itai Pashtan, Nancy Pham, Divya Srivastava, Paul L. Swiecicki, Charlotte Taylor, Matthew E. Witek, Ashley Wysong, David Zander, Ann W. Silk, Anokhi Jambusaria-Pahlajani, Emily Ruiz, Linna L. Gali, Shweta Sharat Kumar
| JAMA Network Verified
Consensus Guidelines for Staging and Surveillance Imaging in Cutaneous Squamous Cell Carcinoma Abstract Importance There is no consensus on staging and surveillance imaging for cutaneous squamous cell carcinoma (CSCC). Although imaging has been shown to affect management, broad recommendations from the National Comprehensive Cancer Network have led to variability in clinical practice.
Open in Who Shared Issue with article?

Prospective MR Evaluation of Endolymphatic Hydrops Using Half-Dose Gadopiclenol

|
By Nancy Fischbein, Lukas D. Landegger, Nancy Pham
| AJNR Podcasts
Abstract BACKGROUND AND PURPOSE: Gadopiclenol is a next-generation macrocyclic gadolinium-based contrast agent (GBCA) distinguished by its high T1 relaxivity and kinetic stability. It was developed to address the clinical need for reduced gadolinium dosing while maintaining high diagnostic accuracy, thereby minimizing potential long-term risks associated with gadolinium retention.
Open in Who Shared Issue with article?

Biopharma Dealmaking Bounced Back In A Big Way In 2025

|
By Joseph Haas Verified, Nancy Pham
| Scrip Verified
INFOGRAPHIC: After M&A and alliance metrics plunged across the board in 2024, 2025 produced significantly higher total and average values in both categories. 2025 marked a return to normalcy for biopharma dealmaking, with increased activity in M&A and alliances (Shutterstock) Key Takeaways Biopharma dealmaking metrics returned to more normal levels in 2025 after a historic downturn in 2024.
Open in Who Shared Issue with article?
See all 78 articles